Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126750
Status:
COMPLETED
Last Update Posted:
2015-07-23
First Post:
2005-08-02
Brief Title:
Web-Enhanced Guideline Implementation for Post MI CBOC Patients
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
MI-Plus Web-enhanced Guideline Implementation for Post MI CBOC Patients
Status:
COMPLETED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VA MI Plus
Brief Summary:
To assist busy primary care clinicians in VA Community Based Outpatient Clinics CBOCs in managing complex patients by providing a single interactive and personalized source of information regarding applicable guidelines for post-MI patients Specifically 1 the investigators will identify barriers to provider adherence to guidelines within VHA clinics 2 Apply guideline-based performance measures to electronic medical records CPRS and associated administrative data 3 Implement the interactive Internet intervention developed by the NHLBI study after inclusion of VA-specific components including performance feedback for CBOC clinicians and 4 Test hypotheses on the interventions effectiveness sustainability and cost-effectiveness in both the VA and Medicare populations This will include a randomized controlled trial with the CBOC as a unit of randomization
Detailed Description:
Some 71 million Americans and an estimated 250000 Veterans actively using VHA are Myocardial Infarction MI survivors To date most guideline interventions focus on a single patient condition but ambulatory post-MI patients are frequently more complex multiple comorbidities and conflicting guidelines applicable to them For example whereas JNC-6 guidelines for the treatment of hypertension suggest pharmacological treatment at blood pressures above 14080 mm Hg to be initiated with diuretics or beta-blockers as first line agents other guidance suggests that for post-MI patients with diabetes treatment cut-offs should be lower and ACE-inhibitors may be considered as optimal first-line agents On October 1 2002 the University of Alabama at Birmingham UAB began a study funded by the National Heart Lung and Blood institute NHLBI as an RO1 Kiefe PI 25 Weissman co-PI 20 to conduct a randomized trial MI-plus to increase provider adherence to guidelines for post-MI patients That NHLBI-funded study targets Medicare beneficiaries and their primary care providers in Alabama Its primary goal is to develop and test with a randomized controlled trial an Internet-based multimodal guideline implementation strategy The investigators propose herewith to extend and adapt this study to a nationwide sample of VA post-MI patients and their primary care providers in the VA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None